Prevalence of multidrug-resistant biofilm-forming pathogens in diabetic foot ulcers and antimicrobial activity of nanoparticles.

INTRODUCTION

Diabetic foot ulcers (DFU) are the main devastating complications for diabetic patients. The involvement of multidrug-resistant microorganisms with the ability to produce biofilms in DFUs renders them difficult to treat. Nanotechnology has emerged as an innovative and promising technology in the therapy of diabetic foot lesions. Therefore, this study was designed to assess the prevalence of drug resistance and biofilm-forming pathogens in DFU and the antimicrobial activity of nanoparticles against these pathogens.

METHODOLOGY

A total of 111 adults with diabetic foot ulcers were randomly included. The clinical parameters and data of the classification and grading of the wound, along with microbiological factors, were analyzed.

RESULTS

Nanoparticles were synthesized from Withania coagulans and Fagonia cretica. The results showed that the majority of patients were male (76%), with an average age of 54 years. The majority of ulcers were polymicrobial (56%), while Staphylococcus aureus (21.2%) was the predominant pathogen. A significant increase in methicillin-resistant Staphylococcus aureus (76.5%), extended-spectrum β-lactamase (ESBL) producers (55.8%), carbapenem-resistant Pseudomonas aeruginosa (46%), and vancomycin-resistant Enterococci (18.1%) was observed. Gram-negative isolates (31%), particularly Pseudomonas aeruginosa, exhibited strong biofilm formation activity compared to gram-positive (6%) and fungal isolates (24%).

CONCLUSIONS

The tested nanoparticles showed significant antimicrobial activity against strong biofilm forming bacterial and fungal isolates. Controlling certain extrinsic and metabolic parameters and comprehensively evaluating nanoparticle-based therapeutics can serve as powerful tools in curing chronic diabetic wounds.